Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biogen Idec
(NQ:
BIIB
)
213.20
+1.31 (+0.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
39
40
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 28, 2022
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Via
InvestorPlace
Why Cassava Sciences Shares Are Soaring Higher
September 28, 2022
Cassava Sciences Inc (NASDAQ: SAVA) shares are trading higher by 7.15 to $49.48 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co.
Via
Benzinga
What's Going On With Eli Lilly Stock Shooting Higher Today
September 28, 2022
Eli Lilly And Co (NYSE: LLY) shares are trading higher by 7.60% to $334.75 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co.
Via
Benzinga
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
September 28, 2022
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.
Via
Benzinga
Biogen Settles For $900M In Bribe Case For Prescribing Multiple Sclerosis Drugs
September 27, 2022
Via
Benzinga
What Are Whales Doing With Biogen
September 12, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Biogen. Looking at options history for Biogen (NASDAQ:BIIB) we detected 28 strange trades.
Via
Benzinga
Nasdaq Futures Slip But S&P 500, Dow Futures Hold Up Ahead Of Market Open — Apple, Biogen Stocks In Focus
September 28, 2022
U.S. stocks could struggle for direction on Wednesday after the market struggled en route to a mixed close in the previous session. Volatility could be the order of the day as another batch of Fed...
Via
Benzinga
Why Biogen Stock Is Up 40% Today
September 28, 2022
Biogen, Inc. (NASDAQ: BIIB) shares are soaring over 43% to their highest level in about a year in premarket trading Wednesday.
Via
Benzinga
Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 28, 2022
U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session.
Via
Benzinga
2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
September 28, 2022
Biogen Inc. (NASDAQ: BIIB) and partner Eisai Co. Ltd.
Via
Benzinga
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
September 28, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Wednesday after closing mostly lower on Tuesday. The S&P 500 index dropped deeper into a bear market after hitting a fresh...
Via
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Biogen, Inc. (NASDAQ: BIIB) and Eisai Co. Ltd. (OTC: ESALY) announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate.
Via
Benzinga
Check Out What Whales Are Doing With BIIB
September 27, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Biogen. Looking at options history for Biogen (NASDAQ:BIIB) we detected 19 strange trades.
Via
Benzinga
Elon Musk Twitter Case Deposition Delayed, FTX US Goes Shopping, Spotify's Analyst Sees Audiobooks Immaterial: Top Financial Media Stories Tuesday, Sept. 27
September 27, 2022
Bloomberg
Via
Benzinga
The 'Transformative' Eli Lilly Drug That Could Top $25 Billion In Annual Sales
September 22, 2022
The drug already has one FDA approval as Lilly angles for a second.
Via
Investor's Business Daily
Novavax Price Target Cut By Around 80%, Plus This Analyst Predicts $129 For NIKE
September 22, 2022
Morgan Stanley cut the price target for NIKE, Inc. (NYSE: NKE) from $149 to $129. NIKE shares fell 0.6% to $99.20 on Thursday.
Via
Benzinga
Longer-Term Use, Early Initiation of Biogen's Experimental Drug For Inherited Rare Disease Slows Disease Progression
September 22, 2022
Via
Benzinga
Looking At Biogen's Recent Whale Trades
September 20, 2022
Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.
Via
Investor's Business Daily
Biogen Whale Trades For September 14
September 14, 2022
Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Hurry! It’s Time to Take Your Profits From These 7 Stocks
September 13, 2022
Investors are increasingly focused on stocks to sell as they brace for a tough September as the economy's challenges mount.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
September 13, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
September 12, 2022
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.
Via
InvestorPlace
Expert Ratings for Biogen
September 12, 2022
Over the past 3 months, 6 analysts have published their opinion on Biogen (NASDAQ:BIIB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...
Via
Benzinga
Has The Controversy Around Falsified Alzheimer's Research Impacted The Path To Finding The Cure?
September 07, 2022
Finding the cure to Alzheimer’s has confounded researchers for decades. As a disease, Alzheimer’s is highly complex and has a wide range of symptoms, including sleeplessness, wandering, agitation,...
Via
Benzinga
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
August 26, 2022
Cassava is reaching the end of its study on Simufilam, an Alzheimer's treatment, and a third insider just bought shares of SAVA stock.
Via
InvestorPlace
7 F-Rated Stocks to Avoid Now
August 12, 2022
The following equities may be household names, but current market conditions mean they’re definitely stocks to avoid now.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could Help
August 11, 2022
Today's depression drugs don't fit many patients' needs. Biotech companies may change that.
Via
Investor's Business Daily
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.